05-Nov-2026 21:27:47

HESTERBIOExpansion

HESTER BIOSCIENCES Q2 FY27 CONCALL: EXPECTS H2 PERFORMANCE IN LINE WITH H1, SUSTAINED POULTRY GROWTH; TARGETS RUMINANT VACCINE EXPANSION, AFRICA COMMERCIALISATION & HIGHER MANUFACTURING UTILISATION

HESTER BIOSCIENCES LTD

← Back to feed